179. Williams syndrome Clinical trials / Disease details
Clinical trials : 5 / Drugs : 14 - (DrugBank : 8) / Drug target genes : 9 - Drug target pathways : 33
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04807517 (ClinicalTrials.gov) | August 1, 2021 | 17/3/2021 | Buspirone Treatment of Anxiety in Williams Syndrome | Buspirone for the Treatment of Anxiety in Williams Syndrome | Williams Syndrome;Anxiety | Drug: Buspirone | Massachusetts General Hospital | NULL | Recruiting | 5 Years | 65 Years | All | 20 | Phase 4 | United States |